# Sodium Phosphates

NDC: 72572-309
Generic name: sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous
Labeler / Manufacturer: Civica, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250813

FDA application: ANDA218314

## Active ingredients

- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS: 142 mg/mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 276 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72572-309"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72572-309
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fd901e6-30cb-411a-b820-b9e79625ec7c